Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04469439 · ClinicalTrials.gov registry record

Impact of Sinus Surgery on Individuals With Cystic Fibrosis

A clinical trial of Cystic Fibrosis and Chronic Rhinosinusitis (Diagnosis), sponsored by University of California, Los Angeles.

Recruiting
Registry status
170
Enrollment target
9
Study locations

NCT04469439: Recruiting study of Cystic Fibrosis and Chronic Rhinosinusitis (Diagnosis), sponsored by University of California, Los Angeles.

NCT04469439 is a study of Cystic Fibrosis and Chronic Rhinosinusitis (Diagnosis) that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 170 participants, roughly in line with the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target. The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04469439, a study of Cystic Fibrosis and Chronic Rhinosinusitis (Diagnosis), is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
170 participants
Enrollment target
9
Study locations

Study Summary

This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control group. Outcomes analyzed will include pulmonary, quality of life, and others.

Primary Outcome

Pulmonary function will be measured using spirometry - the percent of predicted forced expiratory volume in the first second (ppFEV1)

Study Locations (9)

California

  • University of California, Los Angeles - Los Angeles
  • Stanford University - Stanford

Colorado

  • University of Colorado - Aurora
  • National Jewish Health - Denver

North Carolina

  • University of North Carolina - Chapel Hill

Oregon

  • Oregon Health Science University - Portland

South Carolina

  • Medical University of South Carolina - Charleston

Tennessee

  • Vanderbilt University Medical Center - Nashville

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2020-07-01
Est. Completion 2026-01-31

What NCT04469439 shows while recruiting

NCT04469439 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target.

The record links to 2 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 0 interventions.

NCT04469439 lists 9 locations in 7 states (California, Colorado, North Carolina).

Frequently Asked Questions

What is clinical trial NCT04469439 about?

NCT04469439 is a clinical study titled "Impact of Sinus Surgery on Individuals With Cystic Fibrosis". This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control group. Outcomes analyz...

What is the current status of trial NCT04469439?

This trial is currently recruiting. The enrollment target is 170 participants. The study started on 2020-07-01. Estimated completion is 2026-01-31.

What conditions does trial NCT04469439 study?

This clinical trial studies the following conditions: Cystic Fibrosis, Chronic Rhinosinusitis (Diagnosis).

Who is sponsoring clinical trial NCT04469439?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04469439 being conducted?

This trial has 9 study locations across California, Colorado, North Carolina, Oregon, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cystic Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04469439's enrollment target sits among peer trials

170 40th of 169 higher than 130 of 169 other Cystic Fibrosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cystic Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

  • NCT04166409 · 170 participants · Phase 3

    A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04469439, the US trial registry maintained by the National Library of Medicine. NCT04469439 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.